AI-assisted, human-published
09/04/2025 /Funding Events
Revalia Bio Raises $14.5M for Human Organ Trials
Yale spinout Revalia Bio secures $14.5 million in seed funding to pioneer human data trials using perfusion technology, aiming to revolutionize drug development.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com